IMTX · Nasdaq · CIK 0001809196
Immatics N.V.
Immatics N.V.’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 26, 2026. Its EDGAR record lists 11 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Immatics N.V.
- Ticker
- IMTX
- SEC Central Index Key (CIK)
- 0001809196
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) (code 2836)
- Business address
- TUBINGEN, Germany
- State or country of incorporation
- Netherlands
- Fiscal year ends
- December 31
- SEC filer category
- Accelerated filer
- Position in SEC ticker list
- #2343 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Immatics N.V.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in EUR; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | -EUR 93.3M | EUR 27.7M | -EUR 94.6M | EUR 15.2M | -EUR 196.4M |
| Diluted EPS | -EUR 1.48 | EUR 0.40 | -EUR 1.18 | EUR 0.14 | -EUR 1.61 |
| Total assets | EUR 174.6M | EUR 407.8M | EUR 510.0M | EUR 696.1M | EUR 562.3M |
| Cash and equivalents | EUR 133.0M | EUR 148.5M | EUR 218.5M | EUR 236.7M | EUR 345.9M |
XBRL tags used: netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about Immatics N.V., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 26, 2026 | 6-K | Report of a foreign private issuer· period Oct 24, 2026 | Document · Index |
| Oct 23, 2026 | 6-K | Report of a foreign private issuer· period Oct 23, 2026 | Document · Index |
| Aug 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 26, 2026 | Document · Index |
| Aug 27, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Aug 26, 2026 | 6-K | Report of a foreign private issuer· period Aug 26, 2026 | Document · Index |
| Aug 25, 2026 | 424B2 | Prospectus (pricing supplement) | Document · Index |
| Aug 18, 2026 | 6-K | Report of a foreign private issuer· period Jun 30, 2026 | Document · Index |
| Aug 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026 | Document · Index |
| Aug 14, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Jul 29, 2026 | 3 | Initial statement of beneficial ownership· period Jul 20, 2026 | Document · Index |
| Jun 25, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 16, 2026 | Document · Index |
| Jun 18, 2026 | 6-K | Report of a foreign private issuer· period Jun 18, 2026 | Document · Index |
| Jun 2, 2026 | 6-K | Report of a foreign private issuer· period Jun 2, 2026 | Document · Index |
| Jun 1, 2026 | 6-K | Report of a foreign private issuer· period Jun 1, 2026 | Document · Index |
| May 15, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 15, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 15, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| May 15, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 12, 2026 | 6-K | Report of a foreign private issuer· period May 12, 2026 | Document · Index |
| Apr 21, 2026 | 6-K | Report of a foreign private issuer· period Apr 21, 2026 | Document · Index |
| Apr 17, 2026 | 6-K | Report of a foreign private issuer· period Apr 17, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
Insider filing activity
11 Form 4 filings appear in Immatics N.V.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Biological Products, (No Diagnostic Substances)
- AMGN AMGEN INC
- GILD GILEAD SCIENCES, INC.
- MRNA Moderna, Inc.
- ARGX ARGENX SE
- RVMD Revolution Medicines, Inc.
- BIIB BIOGEN INC.
- BNTX BioNTech SE
- EXEL EXELIXIS, INC.
All 61 companies in Biological Products, (No Diagnostic Substances)
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001809196 and XBRL company facts. Immatics N.V. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement